NCT07489261 Effect of Mobile Application- and AI Supported Video-Based Patient Education on Patient Outcomes in Teaching Clean Intermittent Catheterization
| NCT ID | NCT07489261 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mersin University |
| Condition | Clean Intermittent Catheterization |
| Study Type | INTERVENTIONAL |
| Enrollment | 99 participants |
| Start Date | 2026-04-01 |
| Primary Completion | 2026-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 99 participants in total. It began in 2026-04-01 with a primary completion date of 2026-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aimed to determine the effects of a mobile application and an artificial intelligence-supported educational video, developed for patients who will perform clean intermittent catheterization (CIC), on patients' adherence, levels of difficulty, self-confidence, infection parameters (urinalysis, urine culture, infection incidence), and recurrent hospital admissions.The number of CIC patients who applied to the Urology Outpatient Clinic of Mersin University within the last year was 110. Since no similar study was found, the sample size was calculated using an a priori power analysis with G\*Power 3.1.9.7 software. . As a result of the power analysis, the total sample size was calculated as 90, with 30 participants in each group. Considering a possible data loss (dropout) rate of approximately 10%, it was planned to include 33 participants in each group (a total of 99 participants) at the beginning of the study.Data will be collected using the "Descriptive Information Form," "Intermittent Catheterization Adherence Scale," "Self-Confidence Scale in Clean Intermittent Self-Catheterization," "Intermittent Catheterization Difficulty Questionnaire," and the "Patient Follow-up Form."Patients who will perform clean intermittent catheterization will receive training through a mobile application (intervention group 1) and an artificial intelligence-supported educational video (intervention group 2). Patients in the control group will be trained using the routine brochure provided in the outpatient clinic.
Eligibility Criteria
Inclusion Criteria: * Patients who require intermittent catheterization (TAK), * Aged 18 years or older, * Willing to participate in the study, * Able to understand Turkish, * Literate, * Without visual or hearing impairments, * Owning a smartphone, tablet, or computer, * Without difficulties using technology. Exclusion Criteria: * Patients who do not require intermittent catheterization (TAK), * Under 18 years of age, * Not willing to participate in the study, * Do not understand Turkish, * Illiterate, * With visual or hearing impairments, * Do not own a smartphone, tablet, or computer, * Having difficulties using technology.
Contact & Investigator
GAMZE BOZKUL
PRINCIPAL INVESTIGATOR
Tarsus University
Frequently Asked Questions
Who can join the NCT07489261 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Clean Intermittent Catheterization. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07489261 currently recruiting?
Yes, NCT07489261 is actively recruiting participants. Contact the research team at elifeket@yahoo.com for enrollment information.
Where is the NCT07489261 trial being conducted?
This trial is being conducted at Mersin, Turkey (Türkiye).
Who is sponsoring the NCT07489261 clinical trial?
NCT07489261 is sponsored by Mersin University. The principal investigator is GAMZE BOZKUL at Tarsus University. The trial plans to enroll 99 participants.